References
1. Biteker M, Altun I, Basaran O, Dogan V, Yildirim B, Ergun G (2015)
Treatment of Prosthetic Valve Thrombosis: Current Evidence and Future
Directions. J Clin Med Res. 7:932-936.
2. Dulgheru R, Lancellotti P, Dweck MR, Garbi M, Magne J, Nieman K,
Rosenhek R, Bernard A, Lowenstein J, Vieira MLC, Rabischoffsky A,
Vyhmeister RH, Zhou X, Zhang Y, Zamorano J-L, Habib G, Pibarot P,
Chambers J, Edvardsen T, Delgado V, Pepi M, Cosyns B (2016)
Recommendations for the imaging assessment of prosthetic heart valves: a
report from the European Association of Cardiovascular Imaging endorsed
by the Chinese Society of Echocardiography, the Inter-American Society
of Echocardiography, and the Brazilian Department of Cardiovascular
Imaging. Eur Heart J Cardiovasc Imaging. 17:589-590
3. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher
LA, Jneid H, Mack MJ, McLeod CJ, O’Gara PT, Rigolin VH, Sundt TM 3rd,
Thompson A (2017) 2017 AHA/ACC Focused Update of the 2014 AHA/ACC
Guideline for the Management of Patients With Valvular Heart Disease: A
Report of the American College of Cardiology/American Heart Association
Task Force on Clinical Practice Guidelines. J Am Coll Cardiol.
70:252-289.
4. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B,
Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J,
Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano
JL; ESC Scientific Document Group (2017) 2017 ESC/EACTS Guidelines for
the management of valvular heart disease.
Eur Heart J. 38
:2739-2791.
5. Kalçık M, Gürsoy OM, Astarcıoğlu MA, Özkan M (2014) A serial
fluoroscopy-guided thrombolytic therapy of a mechanical tricuspid
prosthetic valve thrombosis with low-dose and ultra-slow infusion of
tissue-type plasminogen activator. Turk Kardiyol Dern Ars. 42:478-481.
6. Özkan M, Çakal B, Karakoyun S, Gürsoy OM, Çevik C, Kalçık M, Oğuz AE,
Gündüz S, Astarcioglu MA, Aykan AÇ, Bayram Z, Biteker M, Kaynak E,
Kahveci G, Duran NE, Yıldız M (2013) Thrombolytic therapy for the
treatment of prosthetic heart valve thrombosis in pregnancy with
low-dose, slow infusion of tissue-type plasminogen activator.
Circulation. 128:532-540.
7. Özkan M, Gündüz S, Biteker M, Astarcioglu MA, Çevik C, Kaynak E,
Yıldız M, Oğuz E, Aykan AÇ, Ertürk E, Karavelioğlu Y, Gökdeniz T, Kaya
H, Gürsoy OM, Çakal B, Karakoyun S, Duran N, Özdemir N (2013) Comparison
of different TEE-guided thrombolytic regimens for prosthetic valve
thrombosis: the TROIA trial. JACC Cardiovasc Imaging. 6:206-216.
8. Zaghloul A, Iorgoveanu C, Desai A, Silkowski M and Balakumaran K
(2018) Prosthetic Tricuspid Valve Thrombosis.
Cureus.
10: e2928.
9. Huang G, Schaff HV, Sundt TM, Rahimtoola SH (2013) Treatment of
obstructive thrombosed prosthetic heart valve. J Am Coll Cardiol.
62:1731-1736.
10. Liu P, Qiao WH, Sun FQ, Ruan XL, Al Shirbini M, Hu D, Chen S, Dong
NG (2016) Should a Mechanical or Biological Prosthesis Be Used for a
Tricuspid Valve Replacement? A Meta-Analysis. J Card Surg. 31:294-302.
11. Roudaut R, Serri K, Lafitte S (2007) Thrombosis of prosthetic heart
valves: diagnosis and therapeutic considerations. Heart. 93:137-142.
12. Sensoy B, Canpolat U, Cay S, Ozeke O, Acikgoz K, Kus O, Tufekcioglu
O (2015) Treatment of mechanical valve thrombosis in the right heart:
overview of the requirements for the new thrombolytic protocols
Blood Coagul
Fibrinolysis. 26:220-222.
13. McElhinney DB, Cabalka AK, Aboulhosn JA, Eicken A, Boudjemline Y,
Schubert S, Himbert D, Asnes JD, Salizzoni S, Bocks ML, Cheatham JP,
Momenah TS, Kim DW, Schranz D, Meadows J, Thomson JD, Goldstein BH,
Crittendon I 3rd, Fagan TE, Webb JG, Horlick E, Delaney JW, Jones TK,
Shahanavaz S, Moretti C, Hainstock MR, Kenny DP, Berger F, Rihal CS,
Dvir D (2016) Transcatheter Tricuspid Valve-in-Valve Implantation for
the Treatment of Dysfunctional Surgical Bioprosthetic Valves: An
International, Multicenter Registry Study. Circulation. 133:1582-1593.
14.
Taherkhani
M,
Hashemi
SR,
Hekmat
M,
Safi
M,
Taherkhani
A,
Movahed
MR (2015) Thrombolytic Therapy for Right-Sided Mechanical Pulmonic and
Tricuspid Valves: The Largest Survival Analysis to Date. Tex Heart Inst
J. 42:543-547.
15. Shapira Y, Sagie A, Jortner R, Adler Y, Hirsch R (1999) Thrombosis
of bileaflet tricuspid valve prosthesis: clinical spectrum and the role
of nonsurgical treatment. Am Heart J. 137:721-725.
16. Zhang DY, Lozier J, Chang R, Sachdev V, Chen MY, Audibert JL,
Horvath KA , Rosing DR (2012) Case study and review: treatment of
tricuspid prosthetic valve thrombosis. Int J Cardiol. 162:14-19.
17. Panduranga P, Al-Mukhaini M, Al-Muslahi M, Haque MA, Shehab A (2012)
Management dilemmas in patients with mechanical heart valves and
warfarin-induced major bleeding World J Cardiol. 4: 54–59.
18. Roudaut R, Lafitte S, Roudaut MF, Reant P, Pillois X, Durrieu-Jais
C, Coste P, Deville C, Roques X (2009) Management of prosthetic heart
valve obstruction: fibrinolysis versus surgery. Early results and
long-term follow-up in a single-centre study of 263 cases.
Arch Cardiovasc
Dis. 102:269-277.
19. Separham A, Ghaffari S, Aslanabadi N, Sohrabi B, Ghojazadeh M,
Anamzadeh E, Hajizadeh R, Davarmoin G (2015) Prosthetic valve
thrombosis. J Card Surg. 30:246-50.
20. Marder VJ and Stewart D. Towards safer thrombolytic therapy (2002)
Semin Hematol.
39:206-216.
21. Özkan M, Kalçık M, Gürsoy MO, Öcal L, Griffini S, Karakoyun S, Yesin
M, Gündüz S, Astarcıoğlu MA, Bayam E, Cerşit S, Aykan AÇ, Cugno M (2016)
Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in
Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial. J
Cardiovasc Pharmacol Ther. 21:372-380.
22. Besir FH, Gul M, Ornek T, Ozer T, Ucan B, Kart L. (2011)
Enoxaparin-associated giant retroperitoneal hematoma in pulmonary
embolism treatment. N Am J Med Sci. 3:524-526.
23. Özkan M, Gündüz S, Gürsoy OM, Karakoyun S, Astarcıoğlu MA, Kalçık M,
Aykan AÇ, Çakal B, Bayram 3, Oğuz AE, Ertürk E, Yesin M, Gökdeniz T,
Duran N3, Yıldız M, Esen AM (2015) Ultraslow thrombolytic therapy: A
novel strategy in the management of PROsthetic MEchanical valve
Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial.
Am Heart J. 170: 409-418.
24. Yaminisharif A, Alemzadeh-Ansari MJ and Ahmadi SH (2012) Prosthetic
tricuspid valve thrombosis: three case reports and literature review. J
Tehran Heart Cent. 7:147-155.
25. Gündüz S, Yesin M, Gürsoy MO, Kalçık M, Özkan M (2015) Management of
Patients With Prosthetic Valve Thrombosis After Failed Thrombolytic
Therapy. J Am Coll Cardiol. 66:875-876.
26. Gündüz S, Özkan M, Kalçik M, Gürsoy OM, Astarcioğlu MA, Karakoyun S,
Aykan AÇ, Biteker M, Gökdeniz T, Kaya H, Yesin M, Duran NE, Sevinç D,
Güneysu T (2015) Sixty-Four-Section Cardiac Computed Tomography in
Mechanical Prosthetic Heart Valve Dysfunction: Thrombus or Pannus. Circ
Cardiovasc Imaging. 8. pii: e003246.
27. Hariram V (2014) Percutaneous management of prosthetic valve
thrombosis. Indian Heart J. 66:427-429.
28. Asmarats L, Houde C, Pasian S, Rodés-Cabau J (2018) Transcatheter
valve-in-valve overexpansion for treating a large dysfunctional
tricuspid bioprosthesis. Interact Cardiovasc Thorac Surg. 26:527-528.
29. Songur CM, Simsek E, Ozen A, Kocabeyoglu S and Donmez TA (2014) Long
term results comparing mechanical and biological prostheses in the
tricuspid valve position: which valve types are better–mechanical or
biological prostheses? Heart Lung Circ. 23:1175-178.